RxDoctor Payments Data

Faisal Razzaqi

Pediatric Hematology-Oncology · Madera, CANPI 1780875658

Payments from drug & device makers

$191,314in general payments, 2019–2025

Across 141 payments — averaging $1356.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$115K
  • Sobi, Inc$45K
  • Jazz Pharmaceuticals Inc.$24K
  • Amgen$7K
  • Astellas Pharma US Inc$178
  • Novartis$151
  • plus $626 from 19 others

What the payments were for

  • Consulting fees$7,1969%
  • Speaking & faculty fees$53,89070%
  • Travel & lodging$12,62216%
  • Food & beverage$2,8534%
  • Education$480%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$191,314 in reported general payments places this provider in the 75th percentile of 307 pediatric hematology-oncology providers in California.

See all pediatric hematology-oncology providers in California

Other pediatric hematology-oncology in Madera

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →